Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia

Clinical trial NCT02098278 · COMPLETED

Trial details

NCT number: NCT02098278
Sponsor: Catabasis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lipoprotein Lipase Deficiency, Familial Hyperlipoproteinemia Type I Chylomicronemia, Familial Hypertriglyceridemia

Start date: 2014-03-01
Primary completion: 2015-04-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.